The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Insulet Corporation (NASDAQ:PODD) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Toward the end of the lightning round, a caller sought Cramer’s opinion of the stock, and he said:

Insulet is the stock in the healthcare group. It is the biggest decline of any stock in the healthcare group, and I looked at it today to see if I could recommend it. It’s still too expensive because of the GLP-1 threat, existential.

Photo by Adam Nowakowski on Unsplash

Insulet Corporation (NASDAQ:PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers the Omnipod platform, including the Omnipod 5 automated insulin delivery system and Omnipod DASH, along with the broader Omnipod Insulin Management System. Parnassus Investments stated the following regarding Insulet Corporation (NASDAQ:PODD) in its third quarter 2025 investor letter:

Insulet Corporation (NASDAQ:PODD) is the sole manufacturer of a tubeless insulin pump to treat diabetes. The company has durable competitive advantages from its intellectual property and proprietary production processes. Insulet’s addressable market has the potential to significantly increase if it expands from Type 1 diabetics to the larger population of Type 2 diabetics.

While we acknowledge the potential of PODD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.